Philogen S.p.A. (PHIL.MI)
EUR 21.7
(-0.46%)
EUR 21.7
(-0.46%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 5.66 Million EUR | -160.41% |
| 2022 | 10.52 Million EUR | 229.38% |
| 2021 | -8.13 Million EUR | -60.98% |
| 2020 | -5.05 Million EUR | -39.38% |
| 2019 | -3.62 Million EUR | -525.59% |
| 2018 | 852 Thousand EUR | 160.6% |
| 2017 | -1.4 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q2 | 7.37 Million EUR | 0.0% |
| 2023 Q3 | -3.74 Million EUR | -150.72% |
| 2023 Q1 | 7.37 Million EUR | 2665.22% |
| 2023 FY | -6.35 Million EUR | -160.41% |
| 2023 Q4 | -3.74 Million EUR | 0.0% |
| 2022 Q4 | -287.5 Thousand EUR | 0.0% |
| 2022 FY | 10.52 Million EUR | 229.38% |
| 2022 Q3 | -287.5 Thousand EUR | -103.78% |
| 2022 Q2 | 7.6 Million EUR | 6.09% |
| 2022 Q1 | 7.16 Million EUR | 186.17% |
| 2021 Q1 | -1.69 Million EUR | -283.6% |
| 2021 FY | -8.13 Million EUR | -60.98% |
| 2021 Q4 | -8.31 Million EUR | -630.26% |
| 2021 Q3 | -1.13 Million EUR | 83.04% |
| 2021 Q2 | -6.71 Million EUR | -295.99% |
| 2020 Q1 | -984 Thousand EUR | -144.85% |
| 2020 FY | -5.05 Million EUR | -39.38% |
| 2020 Q4 | -442 Thousand EUR | 0.0% |
| 2020 Q2 | -984 Thousand EUR | 0.0% |
| 2019 Q4 | 2.19 Million EUR | 0.0% |
| 2019 FY | -3.62 Million EUR | -525.59% |
| 2018 FY | 852 Thousand EUR | 160.6% |
| 2017 FY | -1.4 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| ARTERRA BIOSCIENCE | -157.83 Thousand EUR | 3691.703% |
| Ulisse Biomed S.p.A. | -2.37 Million EUR | 338.547% |